Prot# IPT-2004-001: An Open-Label, Randomized, 2-Way Crossover Study to Assess the Bioequivalence, Pharmacokinetics, Pharmacodynamics, and Safety of Single and Repeat Doses of Somatrem Compared with Protropin®

Project: Research project

Project Details

StatusFinished
Effective start/end date10/5/04 → 3/3/08

Funding

  • PPD Development (IPT-2004-001)
  • Indiana Protein Technologies, Inc. (IPT-2004-001)